• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Collaborative model effective in treating teen depression

byJeffrey CohenandPriyanka Vedak
August 26, 2014
in Chronic Disease, Pediatrics, Psychiatry
Reading Time: 3 mins read
Social integration may reduce suicide risk in male health professionals
Share on FacebookShare on Twitter

1. The utilization of a collaborative care model for adolescents with depression resulted in a greater symptomatic improvement at 12 months when compared to the standard of care. 

2. The inclusion of a collaborative care model in pediatrics practices represents a promising method for treating adolescent depression. 

Evidence Rating Level: 2 (Good)            

Study Rundown: Adolescent depression is an important problem with many long-term ramifications. Nevertheless, only roughly 60% of adolescents with depression receive appropriate treatment.  The many obstacles faced in diagnosing and treating adolescent depression, including the paucity of available pediatric mental health specialists, make managing adolescent depression in primary care settings an important yet challenging goal. In this study, 151 adolescents (13-17 years old) diagnosed with depression using both screening and confirmatory tests were randomized to receive either the standard of care or to be enrolled in a collaborative care model. The collaborative care model involved receiving care from a trained depression case manager (DCM) who assisted with pharmacological management and cognitive behavioral therapy (ROAD Intervention).  The primary outcome was change in Child Depression Rating Scale—Revised (CDRS-R) scores at 12 months.

Overall, the adolescents enrolled in the intervention had a greater decrease in CDRS-R score than those in the control group. The greatest strength of this study was the high level of compliance to treatment regimens noted in each group.  This study was however limited by its small sample size and the homogeneity of its study population; participants were predominantly female and the subject pool was derived from one healthcare system. While all hospitals may not have the available resources to train and utilize DCMs, the results of this study underscore the utility of such collaborative care models in the primary care setting.

Click to read the study, published today in JAMA

RELATED REPORTS

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

Selective serotonin reuptake inhibitors may reduce risk of total joint arthroplasty in osteoarthritis

Use of selective serotonin reuptake inhibitors guided by pharmacogenetic testing may improve treatment response in depression

Click to read an accompanying editorial, published today in JAMA

Relevant Reading: Collaborative care for depression and anxiety problems

In-Depth [randomized controlled trial]: 151 adolescents (13-17 years old) who were diagnosed with depression based on a Patient Health Questionnaire (PHQ)-2 screening test and PHQ-9 confirmatory test were randomized to receive either the standard of care or a collaborative care intervention in their pediatricians’ offices. The collaborative care intervention involved trained DCMs who provided care related to pharmacologic management and cognitive behavioral therapy (ROAD Intervention) for depression.  All included adolescents, 72% of whom were female, had baseline CDRS-R scores recorded, which were compared to their CDRS-R scores at 12 months.  In the intervention group, the mean CDRS-R score went from 48.3 (95% CI 45.5-51.0) to 27.5 (95% CI 23.8-31.1) over 12 months.  In the control group, the mean CDRS-R score went from 46.0 (95% CI 43.1-48.9) to 34.6 (95% CI 30.6-38.6) over 12 months.  Regression model analysis indicated that the intervention group had a 9.4-point greater decrease than the control group over 12 months (p=0.001).  Interaction analysis for time showed that the ROAD intervention yielded more improvement in CDRS-R score over time (Wald c2=7.24, p<0.001).

More from this author: Ambulances equipped for thrombolysis allow for more rapid stroke treatment, Stem cell transplant may be effective in sickle cell disease, Varenicline (Chantix) with nicotine patches effective in smoking cessation, No benefit with hydroxychloroquine (Plaquenil) over placebo in Sjogren’s Syndrome [JOQUER Trial], Economic incentives effective in increasing male circumcision rates in Kenya

Image: PD 

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: depression
Previous Post

Deep brain stimulation may be safe for older Parkinson patients

Next Post

Comorbidities of head and neck cancer may drive malnutrition

RelatedReports

Artificial Intelligence

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

September 11, 2026
Physical therapy reduces pain in adults with knee osteoarthritis
Chronic Disease

Selective serotonin reuptake inhibitors may reduce risk of total joint arthroplasty in osteoarthritis

May 21, 2026
Children’s hospital visits for suicide ideation and attempts are increasing
Chronic Disease

Use of selective serotonin reuptake inhibitors guided by pharmacogenetic testing may improve treatment response in depression

May 13, 2026
Parents often unaware of adolescents’ suicidal thoughts
Psychiatry

Psychotherapy identified as most effective treatment for grief

February 2, 2026
Next Post
Comorbidities of head and neck cancer may drive malnutrition

Comorbidities of head and neck cancer may drive malnutrition

Study shows poor follow up of children with high blood pressure

Guided patient self-management of blood pressure medications effective

Erythropoietin linked with reduced risk of brain injury in preterm infants

Erythropoietin linked with reduced risk of brain injury in preterm infants

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Video mental health care may have clinical advantages versus phone or in-person visits
  • Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring
  • Transanastomotic tubes not linked to anastomotic stricture after esophageal atresia repair
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.